Barry Kennedy

Research Associate, Department of Clinical Translation, IMV Inc.

"Targeted metabolic reprogramming to enhance the efficacy of oncolytic virus-based cancer immunotherapy"

Time

Starts:
Ends:

Location

Microsoft Teams (Online)
Contact bioc@dal.ca to receive the link